Image For Activity Cover
Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients with Heart Failure (JACC April 2023-2)
Some patients with heart failure may experience transient changes in kidney function upon transition to sacubitril/valsartan. Whether such changes portend adverse outcomes or influence long-term treatment benefits with sacubitril/valsartan continuation is unknown.

Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Safia Chatur, MD
Brian L. Claggett, PhD
Finnian R. McCausland, MD
Jean Rouleau, MD
Michael R. Zile, MD
Milton Packer, MD
Marc A. Pfeffer, MD, PhD
Martin Lefkowitz, MD
John JV McMurray, MD
Scott D. Solomon, MD
Muthiah Vaduganathan, MD, MPH 

Important Dates
Date of Release: April 10, 2023
Term of Approval/Date of CME/MOC Expiration: April 9, 2024
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By